Description
Research consortium to perform the REMoxTB clinical trialCoordinating investigator for the registration trial REMoxTB
| Period | 1 Aug 2005 → … |
|---|---|
| Held at | REMoxTB Consortium, United Kingdom |
Keywords
- tuberculosis
- clinical trial
- drug therapy
- diagnostics
Related content
-
Research output
-
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis
Research output: Contribution to journal › Article › peer-review
-
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
Research output: Contribution to journal › Article › peer-review
-
Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis
Research output: Contribution to journal › Letter › peer-review
-
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
Research output: Contribution to journal › Article › peer-review
-
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Research output: Contribution to journal › Article › peer-review
-
The role of moxifloxacin in tuberculosis therapy
Research output: Contribution to journal › Article › peer-review